Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (361-370 of 438) with videos related to

Pageof 44
Sort By:
The Lancet. Microbe|February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.
BMC Infectious Diseases|March 15, 2024
A multi-country comparative study of two treponemal tests for the serodiagnosis of syphilis amongst men who have sex with men (MSM): Chemo-luminescent assay vs Treponema pallidum particle agglutination assayLorenzo Gios, Massimo Mirandola, Maddalena Cordioli, et al.
Sexually Transmitted Infections|October 21, 2020
Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, UgandaFrancis Kakooza, Patrick Musinguzi, Meklit Workneh, et al.
Bulletin of the World Health Organization|August 7, 2019
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016Jane Rowley, Stephen Vander Hoorn, Eline Korenromp, et al.
The Lancet. Public Health|January 7, 2022
Initial impacts of the COVID-19 pandemic on sexual and reproductive health service use and unmet need in Britain: findings from a quasi-representative survey (Natsal-COVID)Emily Dema, Jo Gibbs, Soazig Clifton, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2023
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20Francis Kakooza, Daniel Golparian, Mitch Matoga, et al.
Sexually Transmitted Infections|March 21, 2019
Collecting and exploiting data to understand a nation's sexual health needs: Implications for the British National Surveys of Sexual Attitudes and Lifestyles (Natsal)Catherine H Mercer, Soazig Clifton, Gillian Prior, et al.
Emerging Microbes & Infections|October 23, 2025
Emergence, evolution and temporal spread of ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> in China from 2002 to 2022: a retrospective genomic surveillance studyChi Zhang, Yang Yang, Bangyong Zhu, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16Daniel Golparian, Maria Luiza Bazzo, Lisléia Golfetto, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2020
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunitiesUrsula Theuretzbacher, Lindley Barbee, Kristie Connolly, et al.
Pageof 44

Showing results (361-370 of 438) with videos related to

Sort By:
Pageof 44
The Lancet. Microbe|February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational studyMagnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.
BMC Infectious Diseases|March 15, 2024
A multi-country comparative study of two treponemal tests for the serodiagnosis of syphilis amongst men who have sex with men (MSM): Chemo-luminescent assay vs Treponema pallidum particle agglutination assayLorenzo Gios, Massimo Mirandola, Maddalena Cordioli, et al.
Sexually Transmitted Infections|October 21, 2020
Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, UgandaFrancis Kakooza, Patrick Musinguzi, Meklit Workneh, et al.
Bulletin of the World Health Organization|August 7, 2019
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016Jane Rowley, Stephen Vander Hoorn, Eline Korenromp, et al.
The Lancet. Public Health|January 7, 2022
Initial impacts of the COVID-19 pandemic on sexual and reproductive health service use and unmet need in Britain: findings from a quasi-representative survey (Natsal-COVID)Emily Dema, Jo Gibbs, Soazig Clifton, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2023
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20Francis Kakooza, Daniel Golparian, Mitch Matoga, et al.
Sexually Transmitted Infections|March 21, 2019
Collecting and exploiting data to understand a nation's sexual health needs: Implications for the British National Surveys of Sexual Attitudes and Lifestyles (Natsal)Catherine H Mercer, Soazig Clifton, Gillian Prior, et al.
Emerging Microbes & Infections|October 23, 2025
Emergence, evolution and temporal spread of ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> in China from 2002 to 2022: a retrospective genomic surveillance studyChi Zhang, Yang Yang, Bangyong Zhu, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16Daniel Golparian, Maria Luiza Bazzo, Lisléia Golfetto, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2020
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunitiesUrsula Theuretzbacher, Lindley Barbee, Kristie Connolly, et al.
Pageof 44